Cardiovascular Portfolio
Hypertension and Heart Disease
Key Facts
About Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited is a prominent Indian multinational pharmaceutical company founded in 1959, known for its focus on branded generics and specialty pharmaceuticals. The company has a diversified portfolio spanning cardiovascular, CNS, gastro-intestinal, and anti-diabetic segments, with operations in over 40 countries. Torrent has established itself as a quality manufacturer with multiple FDA-approved facilities and continues to invest in R&D for complex generics and novel drug delivery systems.
View full company profileAbout Recordati
Founded in 1926 by Giovanni Recordati, this Milan-based pharmaceutical group has evolved from a family pharmacy into a global pharmaceutical force with operations in ~150 countries. The company focuses on both common conditions affecting large populations and rare diseases with limited treatment options, operating through integrated R&D, manufacturing, and commercial capabilities. With a market valuation of approximately €10.5 billion and strong presence in Europe, the company continues expanding its specialty and rare disease portfolio while maintaining its commitment to 'unlocking the full potential of life.'
View full company profileAbout Shenzhen Salubris Pharmaceuticals
Shenzhen Salubris Pharmaceuticals Co., Ltd. is a leading Chinese pharmaceutical company that develops, manufactures, and commercializes pharmaceutical products and medical devices. The company has built a diversified portfolio spanning multiple therapeutic areas with a focus on high-quality generic drugs and innovative pharmaceutical solutions. Listed on the Shenzhen Stock Exchange, Salubris has established itself as a significant player in China's pharmaceutical market with strong manufacturing capabilities and expanding R&D operations.
View full company profileAbout Aurobindo Pharma
Aurobindo Pharma Limited is a vertically integrated pharmaceutical company founded in 1986, headquartered in Hyderabad, India. The company has established itself as a major player in the global generics market with a diverse portfolio spanning antibiotics, ARVs, CVS, CNS, gastroenterology, and other therapeutic segments. With multiple manufacturing facilities across India, the US, and other countries, Aurobindo has built a robust supply chain and regulatory compliance framework serving both developed and emerging markets.
View full company profileTherapeutic Areas
Other Hypertension and Heart Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Cardiovascular generics | Alkem Laboratories | Commercial |